These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 6846357

  • 21. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver.
    Kipnis K, King NM, Nelson RM.
    IRB; 2006; 28(2):16-9. PubMed ID: 16770884
    [No Abstract] [Full Text] [Related]

  • 22. ASHP professional policy recommendations--Invitation to comment.
    Am J Health Syst Pharm; 2010 Apr 15; 67(8):e5-10. PubMed ID: 20360574
    [No Abstract] [Full Text] [Related]

  • 23. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C.
    IRB; 1998 Apr 15; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract] [Full Text] [Related]

  • 24. Biotech and pharma face more costly clinical trials.
    Brower V.
    Nat Biotechnol; 1998 Aug 15; 16(8):714. PubMed ID: 9702762
    [No Abstract] [Full Text] [Related]

  • 25. Mission, role, and functions of the P & T Committee.
    Bell JE, Evans PJ, Standish RC.
    Hosp Formul; 1983 Jun 15; 18(6):639-40, 643-6. PubMed ID: 10260202
    [Abstract] [Full Text] [Related]

  • 26. IRB review of adverse events in investigational drug studies.
    Prentice ED, Gordon B.
    IRB; 1997 Jun 15; 19(6):1-4. PubMed ID: 11656910
    [No Abstract] [Full Text] [Related]

  • 27. The changing clinical trials scene: the role of the IRB.
    Mitchell SC, Steingrub J.
    IRB; 1988 Jun 15; 10(4):1-5. PubMed ID: 11650078
    [No Abstract] [Full Text] [Related]

  • 28. Clinical trials face heightened scrutiny as science and commerce appear to merge.
    Lorman AJ.
    J Biolaw Bus; 2001 Jun 15; 4(4):23-32. PubMed ID: 12751494
    [Abstract] [Full Text] [Related]

  • 29. FDA seeks tighter controls over research with human subjects.
    Hershey N, Miller RD.
    Hosp Med Staff; 1978 Dec 15; 7(12):1-7. PubMed ID: 10239337
    [Abstract] [Full Text] [Related]

  • 30. Procedures for emergency or treatment use of investigational drugs.
    Klecker RJ, Cipolle RJ.
    Am J Hosp Pharm; 1987 May 15; 44(5):1086-9. PubMed ID: 3605118
    [Abstract] [Full Text] [Related]

  • 31. JCAHO--clinical indicators--a glimpse into the future.
    Hoffmann RP.
    Hosp Pharm; 1989 Jan 15; 24(1):63-4. PubMed ID: 10291603
    [No Abstract] [Full Text] [Related]

  • 32. Individual researcher liability for clinical research on humans.
    Miller RK.
    J Biolaw Bus; 2003 Jan 15; 6(2):8-16. PubMed ID: 14682365
    [Abstract] [Full Text] [Related]

  • 33. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.
    Goldspiel B, Hoffman JM, Griffith NL, Goodin S, DeChristoforo R, Montello CM, Chase JL, Bartel S, Patel JT.
    Am J Health Syst Pharm; 2015 Apr 15; 72(8):e6-e35. PubMed ID: 25825193
    [No Abstract] [Full Text] [Related]

  • 34. Clinical trials. Agency wants to stop shopping for best deal.
    Malakoff D.
    Science; 2002 Jun 14; 296(5575):1953. PubMed ID: 12065814
    [No Abstract] [Full Text] [Related]

  • 35. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS.
    Nat Rev Drug Discov; 2003 Dec 14; 2(12):949-61. PubMed ID: 14654794
    [No Abstract] [Full Text] [Related]

  • 36. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO.
    Food Drug Cosmet Law J; 1989 Jan 14; 44(1):13-20. PubMed ID: 11651627
    [No Abstract] [Full Text] [Related]

  • 37. Informed consent: the FDA's perspective.
    Bagley G.
    Food Drug Law J; 1993 Jan 14; 48(2):181-6. PubMed ID: 11653141
    [No Abstract] [Full Text] [Related]

  • 38. International research agreement leads to new U.S. guidelines.
    Maloney DM.
    Hum Res Rep; 1995 Apr 14; 10(4):1-2. PubMed ID: 11654182
    [No Abstract] [Full Text] [Related]

  • 39. Controlling investigational drug use in community hospitals.
    Chase PA.
    Am J Hosp Pharm; 1991 Jan 14; 48(1):61-2. PubMed ID: 2000874
    [No Abstract] [Full Text] [Related]

  • 40. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW, Rappaport BA.
    Anesth Analg; 2007 Mar 14; 104(3):479-80. PubMed ID: 17312189
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.